tiprankstipranks
Applied Therapeutics down 84% after receiving CRL from FDA on NDA for govorestat
The Fly

Applied Therapeutics down 84% after receiving CRL from FDA on NDA for govorestat

In after-hours trading, shares are down 84% to $1.34.

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App